FOXD2 and laryngeal carcinoma: To determine the role of FOXD2-AS1 in promoting drug resistance in LSCC, we stably expressed or knocked down FOXD2-AS1 in laryngeal cancer cell lines to perform gain- and loss-of-function experiments in these cells, respectively.